下一代RNA/蛋白质携带载体具有类活动的载体
Tetsuya Nosaka1,2, Junpei Ohtsuka1,2,3, Tomomi Ohtsuka1,2,3
1Department of Microbiology and Molecular Genetics, Mie University Graduate School of Medicine, Tsu, Japan.
Reviews in medical virology
|November 3, 2024
概括
一种新型的非复制病毒载体,BC-PIV,来源于人类类型2型型型流感病毒 (hPIV2),有效地提供外来蛋白质和基因. 这种载体对疫苗开发和潜在的抗瘤疗法充满希望.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 人类类型2型型流感病毒 (hPIV2) 是婴儿感冒的常见原因,具有适合修改的基因表达系统.
- hPIV2的病毒包裹可以被设计成显示外来蛋白质,为新的治疗应用提供潜力.
研究的目的:
- 通过对hPIV2进行基因改造,开发一种非传播性RNA/蛋白质携带载体,称为BC-PIV.
- 评估BC-PIV传递外源基因和蛋白质的能力,以及其作为疫苗载体和抗瘤剂的潜力.
主要方法:
- BC-PIV是通过从hPIV2中删除F基因来创建的,使其在标准细胞中不复制,但在工程Vero/BC-F包装细胞中繁殖.
- 外源基因被插入到BC-PIVRNA基因组中,外来蛋白质 (例如M2e,埃博拉GP,SARS-CoV-2尖端) 被纳入病毒包裹中.
- 通过在动物模型中测量中和抗体诱导来评估输送蛋白质的免疫性.
主要成果:
- BC-PIV成功地将外源基因和蛋白质,包括病毒尖端蛋白,输入细胞.
- 将埃博拉GP和SARS-CoV-2尖端蛋白纳入BC-PIV有效诱导对这些病毒的中和抗体.
- BC-PIV证明了作为疫苗载体和抗瘤病毒应用的潜力.
结论:
- BC-PIV是一种多功能,非复制的病毒载体,能够提供遗传物质和蛋白质.
- 该载体对开发新疫苗来预防传染病和用于癌症治疗具有显著的前景.
更多相关视频
06:21An Ecdysone Receptor-based Singular Gene Switch for Deliberate Expression of Transgene with Robustness, Reversibility, and Negligible Leakiness
Published on: May 7, 2018
6.5K
10:42A Protocol for the Production of Integrase-deficient Lentiviral Vectors for CRISPR/Cas9-mediated Gene Knockout in Dividing Cells
Published on: December 12, 2017
15.1K
相关概念视频
Experimental RNAi
6.1K
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
6.1K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
